Case Study

Metabolomics finds PanK4 to be an Important Regulator of Glucose Uptake and Lipid Metabolism

Obesity-driven insulin resistance and subsequent type II diabetes are significant health burdens in the Western world, currently affecting 38.4 million people in the United States alone. Exercise is key to combating the effects of obesity, and signaling mechanisms associated with exercise-induced metabolic changes may reveal therapeutic targets to aid in the treatment of these metabolic disorders.

Obesity-driven insulin resistance and subsequent type II diabetes are significant health burdens in the Western world, currently affecting 38.4 million people in the United States alone. Exercise is key to combating the effects of obesity, and signaling mechanisms associated with exercise-induced metabolic changes may reveal therapeutic targets to aid in the treatment of these metabolic disorders.

Case Study Cross platform Approach

The Challenge: Promoting metabolic flexibility in skeletal muscle to battle insulin resistance

Skeletal muscle (SkM) helps maintain normal blood sugar levels by internalizing glucose via insulin and then storing it as glycogen. Excessive amounts of glucose and fatty acids caused by prolonged overeating impair mitochondrial function, which leads to insulin resistance and disrupted uptake of glucose and fatty acid oxidation. Pantothenate kinase 4 (PanK4) is an understudied and unique signaling molecule, which lacks classical kinase activity, but instead acts as a phosphatase in certain metabolic pathways that enhance glucose uptake during exercise. With the long-term goal of identifying new therapeutic targets for lowering blood sugar and increasing insulin sensitivity, Miranda-Cervantes and colleagues aimed to characterize the metabolic function of PanK4 in SkM.1

Metabolon’s Insight: Elucidate the role of PanK4 in glucose metabolism and fatty acid oxidation in skeletal muscle

To gain insight into the metabolic function of PanK4 in exercise-induced metabolic changes, SkM-specific PanK4 knockout (PanK4-/-) and wildtype (PanK4+/+) mice were subjected to treadmill running for set times and paces to simulate maximal running capacity and endurance running. Glucose uptake after exercise was measured in tail vein blood. Mice were euthanized shortly after the exercise bout and SkM tissue samples were analyzed using Metabolon’s Global Discovery Panel.

The Solution: PanK4 is a regulator of glucose uptake and fatty acid oxidation

Despite normal levels of precursor fatty acids and carnitine, most fatty acyl carnitines were lower in PanK4-/- muscles. The analysis of fatty acid oxidation pathways showed this was due to the shunting of fatty acids towards storage pathways rather than oxidization, suggesting that PanK4 regulates fatty acid utilization in SkM by promoting their oxidation.

Typically, acetyl-CoA levels regulate the flux of glucose and fatty acids. Metabolomics data showed that SkM acetyl-CoA levels were significantly elevated in PanK4-/- mice. Elevated levels of citrate and malonyl CoA in PanK4-/- mice were also observed. These findings suggest that the absence of PanK4 leads to higher levels of acetyl-CoA and malonyl-CoA, which could impair fatty acid oxidation by decreasing carnitine shuttle-mediated entry of long-chain fatty acids into mitochondria.

Acetyl-CoA levels have been linked to regulation of glucose metabolism by allosterically inhibiting pyruvate dehydrogenase (PDH), an enzyme that facilitates the conversion of pyruvate to acetyl-CoA. Indeed, activity of PDH trended lower in PanK4-/- mice than in controls, even when PDH was in its active form, showing that PanK4 may regulate the metabolism of glucose in addition to metabolism of lipids. This hypothesis was supported by impaired exercise-induced glucose uptake into PanK4-/- SkM as indicated by higher post-exercise blood glucose levels compared to controls. This phenomenon was observed after both maximum capacity and endurance running. Following exercise, SkM acetyl-CoA and citrate concentrations were also higher in PanK4-/- mice that in controls. Overexpressing PanK4 in PanK4-/- mice rescued glucose uptake and normalized SkM acetyl-CoA levels.

The Outcome: A novel potential therapeutic target is identified and characterized

Overall, the findings of this study demonstrate PanK4 as an important regulator of glucose uptake and glucose and lipid metabolism in response to exercise. By advancing our mechanistic understanding of exercise-induced changes to metabolism, novel therapeutic targets can be identified that may aid in the treatment of insulin resistance and other obesity-driven metabolic disturbances.

References

1. Miranda-Cervantes, A., et al., Pantothenate kinase 4 controls skeletal muscle substrate metabolism. Nat Commun, 2025. 16(1): p. 345.

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.